Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nasdaq Biotechnology Ishares ETF (NQ: IBB ) 144.90 +0.66 (+0.46%) Official Closing Price Updated: 4:15 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nasdaq Biotechnology Ishares ETF < Previous 1 2 3 4 5 6 7 8 9 ... 24 25 Next > Healthcare And Biotech Update With Market At 2024 Highs March 20, 2024 The bull market is intact with technology Stocks dominating, but XLV is up 6.89%YTD. Via Talk Markets 3 Biotech ETFs Overdue for a Bounce March 19, 2024 The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback. Via InvestorPlace Topics ETFs Millionaire Makers: 3 Sectors Poised for 20X Gains March 18, 2024 Dive into three explosive sectors that could yield 20X returns for the bold investor. Uncover these potential millionaire makers. Via InvestorPlace Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits March 04, 2024 Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising. Via InvestorPlace 3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 February 26, 2024 Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential. Via InvestorPlace Lottery Preference And Biotech Stocks: Trust The Financials, Not The Science February 25, 2024 Making a bet on biotech/pharma firms that have not yet achieved significant revenue is the equivalent of buying a lottery ticket—with the same poor risk/return relationship. Via Talk Markets Healthcare Stocks Are Looking Better But What About Biotech? February 20, 2024 Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing. Via Talk Markets Has The Solar ETF TAN Bottomed? February 07, 2024 The last swing high before the huge parabolic move in TAN in 2020 was exactly where the current price was. Via Talk Markets Topics ETFs The Transportation Sector Has A Story To Tell February 05, 2024 With the market experiencing a dose of reality on interest rates, we still believe that current rates are not the worst news for the market, depending on where you look. Via Talk Markets Healthcare And Life Science Funds And ETFs Performance 2023-2024 February 05, 2024 Healthcare stocks usually provide a defensive posture to a stock portfolio. Via Talk Markets Topics ETFs AI, Biotech, Energy Sectors Expect M&A Revival For 2024 January 29, 2024 The AI market, along with energy and biotech, are ripe for M&A following the worst performance in almost a decade for deal-making in 2023. Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Top Thematic ETF Ideas For 2024 January 24, 2024 With AI adoption and spending expected to expand this year, new avenues for business growth will open up for tech companies beyond the Magnificent Seven. Via Talk Markets Topics Artificial Intelligence ETFs Exposures Artificial Intelligence Bullish Continuation In '24? 3 Market Areas To Watch January 10, 2024 This article discusses 3 market areas that should outperform dramatically over the next 12 months... Via Talk Markets Markets: Week 1 Week 2 - What's Next Week 3? January 10, 2024 The growth space is getting crowded again, while the Via Talk Markets A Rough Start To 2024 What Might Be In Store For The Rest Of 2024? January 07, 2024 The market was weighed down by several negative factors that began before the bell even rang at Broad and Wall on the first trading day of this New Year. Via Talk Markets Will the Biotech sector sustain its momentum in 2024? January 04, 2024 The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%. Via MarketBeat Topics ETFs US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday? January 03, 2024 The early 2024 sell-off is intensifying on Wall Street, with all major stock averages in the red on the second trading day of 2024. Via Benzinga Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday? January 02, 2024 Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York. Via Benzinga Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback December 29, 2023 Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals. Via Benzinga Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday? December 26, 2023 The U.S. stock market saw modest gains in a session characterized by low trading volumes following the Christmas holiday. The S&P 500 Index gained 0.3% during midday trading in New York, eyeing its... Via Benzinga S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday? December 22, 2023 The S&P 500 and Nasdaq 100 indices are on the verge of achieving an impressive eight consecutive weeks of gains following a more significant decline than expected in the Federal Reserve’s favored... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities US Stocks Bounce; Chipmakers, Cruise Lines Lead, Dollar Falls: What's Driving Markets Thursday? December 21, 2023 On Thursday, Wall Street rebounded into positive territory, following a brief dip experienced on Wednesday. At midday trading New York time, all major stock indices were trading in the green as traders... Via Benzinga Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday? December 20, 2023 Stocks inched higher during midday trading in New York on Wednesday, with the momentum carrying over from the previous day when the tech-heavy Nasdaq 100 achieved fresh record highs. Via Benzinga Biotech Is Coming Back, Can The Run Last? December 11, 2023 The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally. Via Talk Markets MarketBeat Week in Review – 12/4 - 12/8 December 09, 2023 Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week Via MarketBeat Topics Economy Exposures Interest Rates 3 biotech powerhouses poised to thrive amid sector rebound December 08, 2023 If the newfound support and uptrend in the biotech sector last, as the new year quickly approaches, the biotech sector could shift from lagger to leader. Via MarketBeat Topics ETFs Biotech reversal confirmed: what's ahead for the IBB? December 08, 2023 The recent reversal and reclaim of the significant $124 support level in the IBB holds importance, indicating a potential shift in momentum. Via MarketBeat Topics ETFs Biotech And Healthcare Portfolio Playbook For December 2023/24 November 27, 2023 We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January. Via Talk Markets Are You A Trader Or Investor: Biotech Momentum Is Picking Up November 20, 2023 ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. Via Talk Markets Topics ETFs You Don't Have to Pick a Winner in Biotech. Here's Why. November 18, 2023 If you invest over the long term, you'll increase your chances of victory. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 24 25 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.